HOME >> MEDICINE >> NEWS
Interferons for treatment of SARS?

Authors of a research letter in this week's issue of THE LANCET suggest that recombinant interferons - synthetic versions of naturally occurring compounds of the immune system - could be a an effective treatment for Severe Acute Respiratory Syndrome (SARS).

Although antivirals are probably essential for the treatment of SARS-CoV infection, the antiviral ribavirin (a conventional treatment for SARS) is not always effective. Jindrich Cinatl from Frankfurt University Medical School, Germany, and colleagues assessed the antiviral potential of recombinant interferons against two strains of the SARS coronavirus (SARS-CoV) analysed in Frankfurt and Hong Kong. The investigators replicated the virus in two cell lines in a laboratory setting.

Interferon beta was effective in the two cell lines; interferon alpha effectively inhibited SARS-CoV replication, but with a sensitivity index 50-90 times lower than that for interferon beta. Interferon gamma was slightly better than interferon alpha in one of the cell lines, but was completely ineffective in the other cell line.

Jindrich Cinatl comments: "We showed that interferons inhibit SARS-CoV replication in vitro. Interferon beta was most potent, showing prophylactic protection and antiviral potential after infection. Interferon beta could be the drug of choice, alone or in combination with other antiviral drugs, in the treatment of SARS."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
24-Jul-2003


Page: 1

Related medicine news :

1. Hormonal treatment improves survival in high-risk prostate cancer patients
2. Chronic pain treatments more effective when taken together, new study shows
3. Brain activity prior to treatment flags vulnerability to antidepressant side effects
4. Cultural and social factors influence prostate cancer treatment
5. Research offers hope of new treatments for liver damage
6. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
7. Stanford patient is first to test new treatment for peripheral arterial disease
8. Scientist works on innovative treatments for brain tumors
9. Blacks less likely to get expensive, newer heart treatments
10. Growth hormone treatment improves symptoms of metabolic disorder in postmenopausal women
11. Study examines lessons learned at Africas first public antiretroviral treatment clinic

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Interferons for treatment SARS

(Date:3/30/2015)... March 30, 2015 Good Shepherd Children’s Home ... Children’s Home in Murfreesboro provides a Christian-based home, the children ... Christ and his special plan for their life. , ... new day begins as, one-by-one, the children begin to awake ... as the alarm continues to buzz. Sleepily, she crawls ...
(Date:3/30/2015)... KIND LED’s suite of LED grow lights ... 2015. The excellent value and product features of the KIND ... position in the race for the best LED grow light ... suite of grow lights is the 12 band perfect ... (PAR) wavelengths that plants are most likely to use during ...
(Date:3/30/2015)... 2015 Dr. Jeff Farmer now offers mini ... mini implant is placed into the bone, usually without surgery, ... and snapped into place. For those having trouble with dentures ... be the solution. Thousands of patients around the world now ... adhesives. It is all made possible by mini dental implants ...
(Date:3/30/2015)... Houston, Texas (PRWEB) March 30, 2015 Health ... 1 Fitness Trainer in the World Samir Becic, has created ... of State 2015 , which recognizes the world’s fittest leaders ... is the first and only list of its kind to ... and prime ministers. , Among the world leaders profiled on ...
(Date:3/30/2015)... Dr. Jeffrey Allred DDS, with his practice based ... second opinion consultations for patients who need a second ... second opinions show how small percentage of dentistry patients go ... 6%” – says Dr. Allred. , “People should not ... the dental care provider, for the simple fact that every ...
Breaking Medicine News(10 mins):Health News:Good Shepherd Children’s Home Announces 53rd Year of Providing a Safe-Haven for Children in Need 2Health News:Best LED Grow Lights of 2015 Are Being Led By KIND LED 2Health News:Dr. Jeffrey Farmer A Murfreesboro Dentist Announces New High Tech Dentistry 2Health News:The Top 13 Fittest Heads of State: Why Putin Might Be No. 1 in Health and Fitness 2Health News:Allred Dental Offers Complimentary 15 Minute Consults with Dr. Jeffrey Allred in San Marcos, CA 2
(Date:3/30/2015)... March 30, 2015  New York College of Health ... Intellectual Properties portfolio with U.S. Patent #8,996,098 donated by ... patent represents a surgical instrument that allows surgeons to ... it were in the traditional format of a slide ... medical databases during surgery, thus providing the surgeon real ...
(Date:3/30/2015)... , March 30, 2015 DURECT Corporation ... has initiated a multi-dose Phase 1 clinical trial ... molecule in DURECT,s Epigenomic Regulator Program.  DUR-928 is ... may have broad applicability in metabolic diseases such ... steatohepatitis (NASH).  It may also play an important ...
(Date:3/30/2015)... Nutrastar International Inc. (OTCQB: NUIN) ("Nutrastar" or ... branded consumer products, including commercially cultivated Cordyceps Militaris ("Cordyceps"), ... announced its results for the full year ended December ... Full Year Ended December 31, 2014   ... to $43.35 million in full year 2013. ...
Breaking Medicine Technology:World Renowned Inventor Continues To Break Boundaries With Latest Patent 2World Renowned Inventor Continues To Break Boundaries With Latest Patent 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 2DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 3DURECT Announces Initiation of DUR-928 Multi-Dose Phase 1 Study 4Nutrastar International, Inc. Announces Full Year 2014 Results 2Nutrastar International, Inc. Announces Full Year 2014 Results 3Nutrastar International, Inc. Announces Full Year 2014 Results 4Nutrastar International, Inc. Announces Full Year 2014 Results 5Nutrastar International, Inc. Announces Full Year 2014 Results 6Nutrastar International, Inc. Announces Full Year 2014 Results 7Nutrastar International, Inc. Announces Full Year 2014 Results 8Nutrastar International, Inc. Announces Full Year 2014 Results 9
Cached News: